ISPOR Real-World Evidence Summit 28-30 September 2025 | Tokyo, Japan

Published Sep 9, 2025

Lawrenceville, NJ, USA— September 9,  2025—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced details for its ISPOR Real-World Evidence Summit 2025: Through The Lens of Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.

The Summit features plenary sessions, workshops, and breakout discussions on today’s most pressing topics, each tied to the bigger picture of real-world evidence (RWE) including health equity, HTA, value-based healthcare, generative AI, health policy, drug price negotiations, and beyond.

Sessions include:

Plenary 1: Realizing RWE Potential in Asia Pacific: Opportunities, Challenges, and Progress
Monday 29, September 2025  
This plenary session examines the evolving landscape of real-world evidence across the Asia Pacific region, where adoption varies significantly between countries despite growing interest. 

Speakers Include:

  • Moderator: Fei-Yuan Sharon Hsiao, PhD, College of Medicine, National Taiwan University, Taipei, Taiwan
  • Mahendra Kumar Rai, PhD, EVERSANA, Singapore, Singapore
  • Sallie Pearson, PhD, The University of New South Wales, Sydney, Australia
  • Bor-Sheng Ko, PhD, MD, National Taiwan University Hospital, New Taipei City, Taiwan
  • Boxiong Tang, PhD, MD, TZ Health, Collegeville, PA, United States
  • Yoshiaki Uyama, PhD, Pharmaceuticals & Medical Devices Agency (PMDA), Tokyo, Japan

Plenary 2: Building the Future: Advancing Real-World Evidence in Asia Pacific and Beyond Tuesday 30, September This plenary panel explores the future for RWE in HEOR and addresses questions around HEOR and how to optimize the use of RWE.

Speakers Include:

  • Moderator: Paul Scuffham, PhD, Griffith University, Gold Coast, Australia
  • Bruce Crawford, MA, MPH, Vista Health Japan KK, Tokyo, Japan
  •  Jing Wu, PhD, Tianjin University, Tianjin, China
  • Ji-Hye Byun, PhD, Health Insurance Review & Assessment Service, Wonju , Korea
  • Azuana Ramli, PhD, Ministry of Health, Petaling Jaya, Malaysia

ISPOR is recognized globally as the leading professional society for health economics and outcomes research and for its role in improving healthcare decisions. The Summit draws healthcare stakeholders from the region with an interest in HEOR, including researchers and academicians, assessors and regulators, payers and policymakers, the life sciences industry, healthcare providers, and patient engagement organizations.

Additional information on the conference can be found at:
Conference Information | Program | Press | Exhibits & Sponsorship | Registration

###

ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research
(HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website
 | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram  

 

 

 

 

Related Stories

How to Measure Meaningful Benefit for Patients With Rare Diseases

Oct 28, 2026

Value in Health announced the publication of a themed section examining new approaches to measuring meaningful change for patients with rare diseases.

ISPOR Launches Its First Interpretive Report on the HARPER Template

Oct 27, 2026

ISPOR launched its first Interpretive Report on the HARPER Protocol Template, which establishes shared expectations for how researchers should document and communicate the scientific decisions underlying their real-world evidence studies. ISPOR Interpretive Reports are designed to provide everyday language summaries of the Society's reports.

New Research and Policy Priorities Chart a Broader Role for HEOR

Oct 15, 2026

Value in Health announced today the publication of a new commentary that calls for expanding the role of health economics and outcomes research (HEOR) and increasing its impact on real-world decision making.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×